Meeting
2019 ASCO Annual Meeting
First-line (1L) ribociclib (RIB) plus letrozole (LET) for postmenopausal women with hormone receptor-positive (HR+), HER2- advanced breast cancer (ABC): MONALEESA-2 long-term safety results.
Authors
Joyce O'Shaughnessy
Baylor University Medical Center, Texas Oncology, US Oncology, Dallas, TX
Joyce O'Shaughnessy , Mario Campone , Fabrice Andre , Arnd Nusch , Eva-Maria Grischke , Cristian Villanueva , Norbert Marschner , Eric P. Winer , Shani Paluch-Shimon , Karen Rodriguez-Lorenc , Annie Hilliard , Fabienne Le Gac , Antonia Ridolfi , Gabriel N. Hortobagyi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Metastatic
Track
Breast Cancer
Sub Track
Other Breast Cancer Subtypes
Clinical Trial Registration Number
NCT01958021
Citation
J Clin Oncol 37, 2019 (suppl; abstr 1078)
DOI
10.1200/JCO.2019.37.15_suppl.1078
Abstract #
1078
Poster Bd #
159
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
First-line ribociclib plus letrozole for postmenopausal women with hormone receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC): MONALEESA-2 safety results.
First Author: Wolfgang Janni
Poster
2017 ASCO Annual Meeting
Updated results from MONALEESA-2, a phase 3 trial of first-line ribociclib + letrozole in hormone receptor-positive (HR+), HER2-negative (HER2–), advanced breast cancer (ABC).
First Author: Gabriel N. Hortobagyi
Poster
2018 ASCO Annual Meeting
First-line ribociclib (RIB) + letrozole (LET) in hormone receptor-positive (HR+), HER2-negative (HER2–) advanced breast cancer (ABC): MONALEESA-2 biomarker analyses.
First Author: Gabriel N. Hortobagyi
Poster
2015 ASCO Annual Meeting
Long-term safety profile of palbociclib (P) in combination with letrozole (L) as first-line treatment for postmenopausal patients with ER+ and HER2- advanced breast cancer (ABC) (PALOMA-1/TRIO-18).
First Author: Dennis J. Slamon